FDA news. Food and Drug Administration.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D003879:Dermatologic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019829:Nevirapine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D014212:Tretinoin / Q000627:therapeutic use*; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D018894:Reverse Transcriptase Inhibitors; D014212:Tretinoin; D019829:Nevirapine